Skip to main content
Docetaxel demonstrates stronger safety and survival profile than cabazitaxel for prostate cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Docetaxel demonstrates stronger safety and survival profile than cabazitaxel for prostate cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Prostate Cancer
1
1
Biopsy
0
0.67
Cancer
0
0.67
Radical Prostatectomy
0
0.32
Prostatectomy
0
0.22
Specialty
Lead
score
Hematology-Oncology
1
1
Urology
0
1
General Surgery
0
0.7
Pathology & Lab Medicine
0
0.61